CXCL10 levels rose mainly during the final phase of the disease (T2), whereas IFN-γ has a major increment during the PR “intermediate” phase, corresponding to the peak of the clinical manifestation of the exanthem. The gene discussed is CXCL10; the disease is exanthem.